Clinical article · Specialties, Medicines and results

Iron deficiency anaemia in adults: reading the iron studies and finding the cause

Written for
Hospital physicians, emergency doctors and residents
Reading time
7 minutes
Published
Updated

Written by the Sana Health team for clinicians. It summarises published guidance, is not a guideline and has not been peer reviewed. Check current local protocols before acting.

Key points

  • Define anaemia by the reporting laboratory's lower limit, and investigate any degree of anaemia once iron deficiency is established.
  • Ferritin is the most useful single iron test, but it is an acute-phase protein: with active inflammation a ferritin within the reference range does not exclude iron deficiency.
  • About a third of men and postmenopausal women with iron deficiency anaemia have an underlying lesion, so they need gastrointestinal investigation as well as iron.
  • Coeliac serology and urinalysis belong in the first-line work-up of every adult with iron deficiency anaemia.
  • Oral iron given once daily or on alternate days is first line; intravenous iron is for intolerance, failure, malabsorption or when stores must be replaced quickly.
  • Some intravenous formulations, ferric carboxymaltose in particular, commonly cause hypophosphataemia, which matters when infusions are repeated.

Confirming that the anaemia is due to iron deficiency

Iron deficiency progresses from low iron stores to anaemia, and patients can have symptoms such as fatigue, restless legs and pica before the haemoglobin falls [3]. The British Society of Gastroenterology (BSG) advises defining anaemia by the lower limit of the reporting laboratory's range, and investigating any degree of anaemia once iron deficiency is established [2]. Microcytosis and hypochromia support the diagnosis, but the MCV can be normal early on or when B12 or folate deficiency coexists.

Serum ferritin reflects iron stores, and a low ferritin indicates iron deficiency. Ferritin is also an acute-phase protein, however, and rises with inflammation and infection [4]. Ferritin, transferrin saturation, soluble transferrin receptor and the soluble transferrin receptor-ferritin index are all more informative than red-cell indices alone [5]. The American Society of Hematology published evidence-based guidelines on the diagnosis of iron deficiency in 2026, written for all settings worldwide [6]. Laboratories and guidelines still differ in the ferritin thresholds they use, and the local standard applies.

  • Full blood count with MCV, MCH and a reticulocyte count; a blood film if the indices are mixed or other cell lines are abnormal
  • Ferritin, transferrin saturation and CRP, taken together
  • B12 and folate, creatinine and liver tests
  • Coeliac serology (tissue transglutaminase IgA with a total IgA level) and urinalysis for blood
  • Haemoglobin analysis if microcytosis is out of proportion to the anaemia or the patient's ancestry carries a high prevalence of thalassaemia trait

Iron deficiency, anaemia of inflammation, or both

The hardest decisions arise in patients with chronic inflammatory disease, infection, cancer or kidney disease, where hepcidin-driven iron sequestration lowers transferrin saturation even when stores are adequate [7]. The table summarises the usual patterns; real patients often sit between columns.

TestIron deficiencyAnaemia of inflammationBoth together
FerritinLowNormal or raisedLow-normal or normal, and falsely reassuring
Transferrin saturationLowLow or normalLow
MCVFalls as deficiency progressesUsually normal, sometimes mildly lowOften low
Soluble transferrin receptorRaisedUsually normalRaised
CRPNormal unless another causeRaisedRaised

Consider a patient with rheumatoid arthritis, haemoglobin 86 g/L, MCV 71 fL, ferritin 68 micrograms/L, transferrin saturation 9% and CRP 54 mg/L. The ferritin lies within most reference ranges, but with a CRP of this order it no longer excludes iron deficiency. The marked microcytosis and very low transferrin saturation point towards true iron deficiency, alone or with anaemia of inflammation, and anti-inflammatory drugs make gastrointestinal loss plausible. A soluble transferrin receptor or reticulocyte haemoglobin content can help, the response to iron is itself informative, and the source of loss still has to be sought.

Definitions vary with the setting. Heart failure trials such as AFFIRM-AHF defined iron deficiency as ferritin below 100 micrograms/L, or 100 to 299 micrograms/L with transferrin saturation below 20% [12]. In chronic kidney disease, inflammation makes both transferrin saturation and ferritin poorer guides to the iron the marrow can use, and nephrology guidance applies.

Who needs investigation for a source

About a third of men and postmenopausal women presenting with iron deficiency anaemia have an underlying pathological abnormality [1]. Gastrointestinal blood loss from colonic or gastric cancer, and malabsorption from coeliac disease, are the causes that most need to be found, and the lower the haemoglobin, the more likely serious pathology and the more urgent the investigation [2].

  1. Take a focused history: diet, aspirin, NSAIDs and anticoagulants, menstrual loss, pregnancies, blood donation, previous gastric or bariatric surgery, weight loss, change in bowel habit, and family history of colorectal cancer or haemoglobinopathy.
  2. Send coeliac serology and test the urine for blood in every adult; guidelines recommend coeliac screening in iron deficiency anaemia, and a meta-analysis of biopsy-confirmed disease supports this [11].
  3. In men and postmenopausal women, arrange upper and lower gastrointestinal endoscopy unless there is a strong reason not to, as both the BSG and the American Gastroenterological Association advise [1, 9]; CT colonography is an alternative where colonoscopy is unsuitable.
  4. In premenopausal women, menstrual loss and pregnancy are the commonest causes; reserve endoscopy for gastrointestinal symptoms, a strong family history, or deficiency that persists despite treatment.
  5. If bidirectional endoscopy is normal and the anaemia recurs or does not respond, consider small-bowel investigation, usually capsule endoscopy.

Iron deficiency is especially common in low- and middle-income countries [7]. In much of India, dietary deficiency, closely spaced pregnancies and hookworm infection are frequent causes, but they do not remove the need to investigate older adults and anyone with alarm features.

Oral iron: once daily or on alternate days

Oral iron is first-line treatment for most patients [7]. Each oral dose raises serum hepcidin, which reduces absorption from doses given later that day or the next day [7, 8]. In two randomised studies in iron-depleted women, giving iron on alternate days improved fractional absorption compared with consecutive days, and splitting the daily dose did not improve total absorption [8]. The 2021 BSG guideline recommends one tablet a day, with alternate-day dosing, a different preparation or intravenous iron when this is not tolerated [1].

  • Check the haemoglobin within the first few weeks; an adequate rise supports both the diagnosis and the chosen route.
  • Continue after the haemoglobin has normalised to replenish stores, then check the blood count periodically, because recurrence prompts reinvestigation.
  • If the response is poor, consider non-adherence, continuing loss, malabsorption (coeliac disease, Helicobacter pylori, atrophic gastritis, proton pump inhibitors, bariatric surgery), a coexisting deficiency, or a different diagnosis such as thalassaemia trait.

When intravenous iron is the better choice

  • Intolerance of oral iron, or no response despite adherence
  • Malabsorption, including coeliac disease, inflammatory bowel disease and previous bariatric surgery
  • Continuing losses that oral iron cannot match
  • A need to replace stores quickly, for example before major surgery or late in pregnancy
  • Heart failure with iron deficiency, where intravenous ferric carboxymaltose has been tested in trials such as AFFIRM-AHF [12], and chronic kidney disease, following cardiology and nephrology guidance

Intravenous iron corrects the deficit in one or two infusions, but certain formulations cause hypophosphataemia mediated by fibroblast growth factor 23. In two randomised trials, hypophosphataemia was considerably more frequent after ferric carboxymaltose than after ferric derisomaltose (iron isomaltoside) [10]. It is often asymptomatic, but phosphate should be checked in patients who need repeated infusions or who develop bone pain or weakness.

Formulations, doses and infusion protocols differ between countries and hospitals. Follow the local formulary and haematology or gastroenterology guidance, and observe patients during and after infusion as the product information requires.

How Sana Health helps

Given a full blood count, iron studies and CRP, the Lab Results Interpreter reads ferritin against the inflammatory markers rather than on its own, says whether the pattern favours iron deficiency, anaemia of inflammation, thalassaemia trait or a combination, and orders the next tests, such as a reticulocyte count, soluble transferrin receptor, coeliac serology or haemoglobin analysis. It flags findings that need prompt gastrointestinal referral, uses the laboratory's reference ranges where they are supplied, and ends with references read from PubMed when the question is asked.

Questions

What ferritin level confirms iron deficiency when the CRP is raised?

No single cut-off works in every setting. Because ferritin rises with inflammation, a value within the reference range does not exclude iron deficiency when CRP is raised, and guidelines accept higher thresholds in that situation. Heart failure trials, for example, used ferritin below 100 micrograms/L, or 100 to 299 micrograms/L with transferrin saturation below 20%. Transferrin saturation, soluble transferrin receptor and the response to iron help, and the local laboratory's and guideline's thresholds apply.

Does every adult with iron deficiency anaemia need an endoscopy?

Men and postmenopausal women generally need upper and lower gastrointestinal investigation, because a significant minority have an underlying lesion, including cancer. Premenopausal women are investigated selectively, according to symptoms, family history and response to treatment. Every adult should have coeliac serology and urinalysis.

Is alternate-day oral iron as good as daily iron?

Absorption studies in iron-depleted women showed better fractional absorption with alternate-day dosing, because each dose raises hepcidin, which reduces absorption from the next dose. Alternate-day dosing is a reasonable option, particularly when daily iron causes side effects; the haemoglobin response should be checked whichever schedule is used.

References

  1. British Society of Gastroenterology guidelines for the management of iron deficiency anaemia in adults (opens in a new tab)Gut, 2021
  2. Guidelines for the management of iron deficiency anaemia (opens in a new tab)Gut, 2011
  3. Iron Deficiency in Adults: A Review (opens in a new tab)JAMA, 2025
  4. Serum or plasma ferritin concentration as an index of iron deficiency and overload (opens in a new tab)Cochrane Database Syst Rev, 2021
  5. Iron deficiency anaemia (opens in a new tab)Lancet, 2016
  6. American Society of Hematology 2026 guidelines for diagnosis of iron deficiency (opens in a new tab)Blood Adv, 2026
  7. Iron deficiency (opens in a new tab)Lancet, 2021
  8. Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials (opens in a new tab)Lancet Haematol, 2017
  9. AGA Clinical Practice Guidelines on the Gastrointestinal Evaluation of Iron Deficiency Anemia (opens in a new tab)Gastroenterology, 2020
  10. Effects of Iron Isomaltoside vs Ferric Carboxymaltose on Hypophosphatemia in Iron-Deficiency Anemia: Two Randomized Clinical Trials (opens in a new tab)JAMA, 2020
  11. Prevalence of Celiac Disease in Patients With Iron Deficiency Anemia-A Systematic Review With Meta-analysis (opens in a new tab)Gastroenterology, 2018
  12. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial (opens in a new tab)Lancet, 2020